Literature DB >> 26349991

Effect of DNA methylation profile on OATP3A1 and OATP4A1 transcript levels in colorectal cancer.

Agnieszka Anna Rawłuszko-Wieczorek1, Nikodem Horst2, Karolina Horbacka2, Artur Szymon Bandura1, Monika Świderska1, Piotr Krokowicz2, Paweł Piotr Jagodziński3.   

Abstract

Epidemiological studies indicate that 17β-estradiol (E2) prevents colorectal cancer (CRC). Organic anion transporting polypeptides (OATPs) are involved in the cellular uptake of various endogenous and exogenous substrates, including hormone conjugates. Because transfer of estrone sulfate (E1-S) can contribute to intra-tissue conversion of estrone to the biologically active form -E2, it is evident that the expression patterns of OATPs may be relevant to the analysis of CRC incidence and therapy. We therefore evaluated DNA methylation and transcript levels of two members of the OATP family, OATP3A1 and OATP4A1, that may be involved in E1-S transport in colorectal cancer patients. We detected a significant reduction in OATP3A1 and a significant increase in OATP4A1 mRNA levels in cancerous tissue, compared with histopathologically unchanged tissue (n=103). Moreover, we observed DNA hypermethylation in the OATP3A1 promoter region in a small subset of CRC patients and in HCT116 and Caco-2 colorectal cancer cell lines. We also observed increased OATP3A1 transcript following treatment with 5-aza-2-deoxycytidine and sodium butyrate. The OATP4A1 promoter region was hypomethylated in analyzed tissues and CRC cell lines and was not affected by these treatments. Our results suggest a potential mechanism for OATP3A1 downregulation that involves DNA methylation during colorectal carcinogenesis.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; DNA methylation; OATP3A1; OATP4A1

Mesh:

Substances:

Year:  2015        PMID: 26349991     DOI: 10.1016/j.biopha.2015.08.026

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  5-Aza-2'-deoxycytidine induces a greater inflammatory change, at the molecular levels, in normoxic than hypoxic tumor microenvironment.

Authors:  Ísis Salviano Soares de Amorim; Juliana Alves Rodrigues; Pedro Nicolau; Sandra König; Carolina Panis; Adenilson de Souza da Fonseca; Andre Luiz Mencalha
Journal:  Mol Biol Rep       Date:  2021-02-05       Impact factor: 2.316

2.  Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer.

Authors:  Myung Jin Ban; Sang Hee Ji; Chi-Kyu Lee; Sang Byung Bae; Han Jo Kim; Tae Sung Ahn; Moon Soo Lee; Moo-Jun Baek; Dongjun Jeong
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-04       Impact factor: 4.553

3.  Transcriptional Regulation of Solute Carrier (SLC) Drug Transporters.

Authors:  Shiwei Zhou; Yan Shu
Journal:  Drug Metab Dispos       Date:  2022-05-29       Impact factor: 3.579

4.  LncRNA SLCO4A1-AS1 modulates colon cancer stem cell properties by binding to miR-150-3p and positively regulating SLCO4A1.

Authors:  Kun Wu; Ting Xu; Xudong Song; Jie Shen; Shutao Zheng; Li Zhang; Guoquan Tao; Baofei Jiang
Journal:  Lab Invest       Date:  2021-05-06       Impact factor: 5.662

5.  Estrone Sulfate Transport and Steroid Sulfatase Activity in Colorectal Cancer: Implications for Hormone Replacement Therapy.

Authors:  Lorna C Gilligan; Ali Gondal; Vivien Tang; Maryam T Hussain; Anastasia Arvaniti; Anne-Marie Hewitt; Paul A Foster
Journal:  Front Pharmacol       Date:  2017-03-07       Impact factor: 5.810

6.  Signature Panel of 11 Methylated mRNAs and 3 Methylated lncRNAs for Prediction of Recurrence-Free Survival in Prostate Cancer Patients.

Authors:  Jiarong Cai; Fei Yang; Xuelian Chen; He Huang; Bin Miao
Journal:  Pharmgenomics Pers Med       Date:  2021-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.